Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpel Priv Eqty Regulatory News (JPEL)

Share Price Information for Jpel Priv Eqty (JPEL)

Share Price is delayed by 15 minutes
Get Live Data
1.24    0.00 (0.00%)
Bid:
1.20
Ask:
1.28
Spread: 0.08 (6.667%)
Market Cap: $21.21m
JPEL Live PriceLast checked at - London Stock Exchange

Intraday Jpel Priv Eqty Share Chart

Acquisition

9 Sep 2011 15:15

RNS Number : 9824N
J.P. Morgan Private Equity Ltd
09 September 2011
 



 

 

J.P. MORGAN PRIVATE EQUITY LIMITED ANNOUNCESAPPROVAL OF ACQUISITION OF A PORTFOLIO OF PRIVATE EQUITY CO-INVESTMENTSBY THE SPL FUNDS AND ISSUE OF EQUITY

 

ALL SHARE TRANSACTION VALUED AT APPROXIMATELY US$91.9 MIllION

 

* * *

 

·; SPL Funds have announced that their shareholders have voted in favour of the proposed acquisition by JPEL

·; All-stock acquisition of portfolio of 38 mid-market buyout co-investments

·; £56.5 million purchase price using £36.7 million of US$ Equity Shares and £19.8 million of a new class of ZDP Shares due 2017

·; Purchase price represents a discount to 30 June 2011 Co-Investment Portfolio NAV

·; Acquisition is expected to be accretive to JPEL NAV and enhance 2013 and 2015 ZDP Share cover

·; Expected to generate positive growth and distributions from near-term exits

o Repositions JPEL's portfolio: adds mid-market buyout assets, primarily in the UK, Germany and France

o Enhances JPEL's balance sheet: adds mature assets with meaningful liquidity in 1-2 years

o Differentiates JPEL amongst secondary players and listed private equity peers

·; JPEL has allotted and issued to the SPL Funds, conditional only upon Admission, 44,727,053 new US$ Equity Shares and 30,410,753 New 2017 ZDP Shares

·; It is expected that the new shares will be admitted to listing and to trading at 8.00 a.m. on 12 September 2011

 

 

GUERNSEY, 9 SEPTEMBER 2011

 

J.P. Morgan Private Equity Limited ("JPEL" or the "Company") is very pleased to announce that the SPL Funds, as sellers, have today announced that their shareholders have voted in favour the proposed acquisition by JPEL of the SPL Funds' limited partnership interests (the "Acquisition") in a portfolio of co-investments ("Co-Investment Portfolio").

 

The Co-Investment Portfolio is managed by Parallel Private Equity Limited Partnership and consists of a pool of 38 middle-market co-investments with leading fund managers primarily invested in the UK, Germany and France.

 

JPEL announced the all-share transaction valued at £56.5 million or approximately US$91.9 million on 16 August 2011.

 

The Acquisition is unconditional in all material respects other than admission of the new US$ Equity Shares (JPEL.LN) and New 2017 ZDP Shares (JPSZ.LN) (to be issued as consideration for the Acquisition) to listing on the UKLA's Official List and to trading on the London Stock Exchange ("Admission").

 JPEL can confirm that it has today allotted and issued to the SPL Funds, conditional only upon Admission, 44,727,053 new US$ Equity Shares and 30,410,753 New 2017 ZDP Shares. It is expected that the new shares will be admitted to listing and to trading at 8.00 a.m. on 12 September 2011.Unless otherwise defined in this announcement, defined terms contained herein shall have the meaning given to them in the Company's announcement relating to the Acquisition on 16th August 2011.

 

ENQUIRIES

 

J.P. Morgan Private Equity Limited 

Troy Duncan: Tel (Direct): +44 207 742 3032 (troy.duncan@jpmorgan.com)

Gregory Getschow: Tel (Direct): +1 212 648 1151 (gregrory.getschow@jpmorgan.com)

Rosemary DeRise: Tel (Direct): +1 212 648 2980 (rosemary.derise@jpmorgan.com)

Samantha Ladd: Tel (Direct): +1 212 648 2982 (samantha.ladd@jpmorgan.com)

 

Peregrine Communications

Anthony Payne: Tel (Direct): +44 203 178 6869 (anthony.payne@peregrinecommunications.com)

 

Liberum Capital Limited (Sponsor to the Company and Broker to the Placing)

Steve Pearce / Tom Fyson / Christopher Britton: Tel (Direct): +44 (0)20 3100 2000

 

* * *

 

 

About J.P. Morgan Private Equity Limited

 

J.P. Morgan Private Equity Limited is a Guernsey registered and incorporated closed-ended investment company and is designed primarily to invest in the global private equity market. The Company's issued share capital has been admitted to listing on the premium segment and the standard segment (as appropriate) of the Official List and admitted to trading on the main market of the London Stock Exchange (LSE:JPEL, JPEZ, JPZZ, JPWW). In summary, the investment objective of the Company is to achieve both short and long-term capital appreciation by investing in a well-diversified portfolio of private equity fund interests and by capitalising on the inefficiencies of the secondary private equity market.

 

END

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQUGURCBUPGGWB
Date   Source Headline
9th Nov 20224:11 pmRNS2022 AGM CIRCULAR
27th Oct 20226:26 pmRNSNet Asset Value - September 2022
23rd Sep 20224:54 pmRNSAnnual Financial Report - 30 June 2022
13th Sep 20223:03 pmRNSNet Asset Value(s) - June 2022
13th Jul 202211:36 amRNSNet Asset Value(s) - May 2022
6th Jul 20224:26 pmRNSHolding(s) in Company
6th Jul 20227:00 amRNSUpdate to Shareholders
23rd Jun 20225:10 pmRNSNet Asset Value(s) - April 2022
17th May 20227:00 amRNSNet Asset Value(s) - March 2022
11th May 202211:27 amRNSNet Asset Value - February 2022
6th May 20227:00 amRNSNet Asset Value - January 2022
5th May 20225:39 pmRNSHolding(s) in Company
3rd May 20227:00 amRNSPortfolio Update
11th Apr 202212:34 pmRNSCompletion of Tenth Mandatory Redemption
4th Apr 20227:00 amRNSTenth Mandatory Redemption
17th Mar 20225:35 pmRNSHalf-year Report - 31 December 2021
7th Mar 20229:44 amRNSNet Asset Value - December 2021
19th Jan 20221:47 pmRNSNet Asset Value - November 2021
22nd Dec 20214:24 pmRNSNet Asset Value - October 2021
23rd Nov 20212:13 pmRNSAGM Results 2021
16th Nov 20214:42 pmRNSNet Asset Value - September 2021
3rd Nov 202112:29 pmRNSNet Asset Value - August 2021
2nd Nov 20211:49 pmRNS2021 AGM CIRCULAR
28th Oct 20217:00 amRNSHolding(s) in Company
26th Oct 20214:03 pmRNSHolding(s) in Company
25th Oct 20215:52 pmRNSNet Asset Value - July 2021
30th Sep 20218:27 amRNSAnnual Financial Report - 30 June 2021
12th Aug 20217:00 amRNSCompletion of Ninth Mandatory Redemption
5th Aug 20217:00 amRNSNinth Mandatory Redemption
4th Aug 20213:45 pmRNSNet Asset Value - June 2021
23rd Jul 20213:52 pmRNSLargest Investment Sale & 9th Mandatory Redemption
21st Jul 20213:16 pmRNSNet Asset Value - May 2021
3rd Jun 20213:59 pmRNSNet Asset Value - April 2021
14th May 20213:52 pmRNSNet Asset Value - March 2021
19th Apr 20219:34 amRNSNet Asset Value - February 2021
6th Apr 20217:00 amRNSHolding(s) in Company
1st Apr 20214:21 pmRNSHolding(s) in Company
31st Mar 20215:17 pmRNSNet Asset Value - January 2021
17th Mar 20215:13 pmRNSHalf-year Report - 31 December 2020
24th Feb 20214:35 pmRNSNet Asset Value - December 2020
28th Jan 20215:27 pmRNSHolding(s) in Company
25th Jan 20214:49 pmRNSHolding(s) in Company
15th Jan 20212:01 pmRNSNet Asset Value - November 2020
14th Jan 20213:30 pmRNSHolding(s) in Company
30th Dec 20207:00 amRNSCompletion of 8th Mandatory Redemption
17th Dec 20207:00 amRNSLargest Investment & 8th Mandatory Redemption
11th Dec 20203:01 pmRNSNet Asset Value - October 2020
26th Nov 202010:43 amRNSAGM Results 2020
26th Nov 202010:16 amRNSAGM Results 2020
20th Nov 20207:00 amRNSNet Asset Value - September 2020

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.